Cite
HARVARD Citation
Tuominen, R. et al. (n.d.). MGMT promoter methylation is associated with temozolomide response and prolonged progression‐free survival in disseminated cutaneous melanoma. International journal of cancer. 136 (12), pp. 2844-2853. [Online].